nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—Pleuritic pain—Topotecan—cervical cancer	0.0269	0.191	CcSEcCtD
Dipyridamole—PDE6A—mammalian vulva—cervical cancer	0.0165	0.0382	CbGeAlD
Dipyridamole—PRUNE—uterine cervix—cervical cancer	0.012	0.0276	CbGeAlD
Dipyridamole—PDE6D—uterine cervix—cervical cancer	0.0116	0.0267	CbGeAlD
Dipyridamole—PDE6D—decidua—cervical cancer	0.011	0.0254	CbGeAlD
Dipyridamole—PDE11A—epithelium—cervical cancer	0.0107	0.0246	CbGeAlD
Dipyridamole—PRUNE—uterus—cervical cancer	0.00997	0.023	CbGeAlD
Dipyridamole—PDE6D—uterus—cervical cancer	0.00963	0.0223	CbGeAlD
Dipyridamole—PDE7A—renal system—cervical cancer	0.00881	0.0204	CbGeAlD
Dipyridamole—PDE6D—female reproductive system—cervical cancer	0.00865	0.02	CbGeAlD
Dipyridamole—PRUNE—female gonad—cervical cancer	0.00815	0.0188	CbGeAlD
Dipyridamole—PDE6D—female gonad—cervical cancer	0.00788	0.0182	CbGeAlD
Dipyridamole—PDE6D—vagina—cervical cancer	0.00783	0.0181	CbGeAlD
Dipyridamole—PDE6B—vagina—cervical cancer	0.0077	0.0178	CbGeAlD
Dipyridamole—PDE7A—female reproductive system—cervical cancer	0.00706	0.0163	CbGeAlD
Dipyridamole—PDE2A—uterine cervix—cervical cancer	0.00687	0.0159	CbGeAlD
Dipyridamole—Rigors—Topotecan—cervical cancer	0.00662	0.047	CcSEcCtD
Dipyridamole—PDE8B—uterine cervix—cervical cancer	0.00655	0.0151	CbGeAlD
Dipyridamole—PDE2A—decidua—cervical cancer	0.00654	0.0151	CbGeAlD
Dipyridamole—PDE10A—decidua—cervical cancer	0.00654	0.0151	CbGeAlD
Dipyridamole—PDE2A—mammalian vulva—cervical cancer	0.00601	0.0139	CbGeAlD
Dipyridamole—PDE8A—uterine cervix—cervical cancer	0.00589	0.0136	CbGeAlD
Dipyridamole—PDE1C—lymph node—cervical cancer	0.00581	0.0134	CbGeAlD
Dipyridamole—PDE2A—uterus—cervical cancer	0.00573	0.0132	CbGeAlD
Dipyridamole—PDE1A—uterine cervix—cervical cancer	0.00571	0.0132	CbGeAlD
Dipyridamole—PDE8A—decidua—cervical cancer	0.00562	0.013	CbGeAlD
Dipyridamole—PDE8B—uterus—cervical cancer	0.00546	0.0126	CbGeAlD
Dipyridamole—PDE1A—renal system—cervical cancer	0.00534	0.0123	CbGeAlD
Dipyridamole—PDE8A—endometrium—cervical cancer	0.00533	0.0123	CbGeAlD
Dipyridamole—PRUNE—lymph node—cervical cancer	0.00524	0.0121	CbGeAlD
Dipyridamole—PDE8A—mammalian vulva—cervical cancer	0.00516	0.0119	CbGeAlD
Dipyridamole—PDE2A—female reproductive system—cervical cancer	0.00515	0.0119	CbGeAlD
Dipyridamole—PDE1B—female reproductive system—cervical cancer	0.0051	0.0118	CbGeAlD
Dipyridamole—PDE6D—lymph node—cervical cancer	0.00506	0.0117	CbGeAlD
Dipyridamole—PDE8A—uterus—cervical cancer	0.00491	0.0114	CbGeAlD
Dipyridamole—PDE8B—female reproductive system—cervical cancer	0.00491	0.0113	CbGeAlD
Dipyridamole—PDE1A—uterus—cervical cancer	0.00475	0.011	CbGeAlD
Dipyridamole—PDE10A—female gonad—cervical cancer	0.00468	0.0108	CbGeAlD
Dipyridamole—PDE2A—vagina—cervical cancer	0.00465	0.0108	CbGeAlD
Dipyridamole—ADA—decidua—cervical cancer	0.00462	0.0107	CbGeAlD
Dipyridamole—Ear pain—Topotecan—cervical cancer	0.0046	0.0326	CcSEcCtD
Dipyridamole—ADA—renal system—cervical cancer	0.00454	0.0105	CbGeAlD
Dipyridamole—PDE4A—decidua—cervical cancer	0.0045	0.0104	CbGeAlD
Dipyridamole—PDE6G—lymph node—cervical cancer	0.00446	0.0103	CbGeAlD
Dipyridamole—PDE8B—vagina—cervical cancer	0.00444	0.0103	CbGeAlD
Dipyridamole—PDE1A—female reproductive system—cervical cancer	0.00427	0.00988	CbGeAlD
Dipyridamole—ADA—mammalian vulva—cervical cancer	0.00424	0.00981	CbGeAlD
Dipyridamole—PDE5A—epithelium—cervical cancer	0.00405	0.00937	CbGeAlD
Dipyridamole—Anaphylactoid reaction—Topotecan—cervical cancer	0.00405	0.0288	CcSEcCtD
Dipyridamole—PDE5A—uterine cervix—cervical cancer	0.00402	0.00929	CbGeAlD
Dipyridamole—PDE8A—female gonad—cervical cancer	0.00402	0.00929	CbGeAlD
Dipyridamole—PDE8A—vagina—cervical cancer	0.00399	0.00923	CbGeAlD
Dipyridamole—PDE1A—female gonad—cervical cancer	0.00389	0.00899	CbGeAlD
Dipyridamole—PDE5A—renal system—cervical cancer	0.00376	0.00869	CbGeAlD
Dipyridamole—Cardiac arrest—Topotecan—cervical cancer	0.00373	0.0265	CcSEcCtD
Dipyridamole—ABCC5—uterine cervix—cervical cancer	0.00368	0.0085	CbGeAlD
Dipyridamole—ADA—female reproductive system—cervical cancer	0.00363	0.0084	CbGeAlD
Dipyridamole—PDE7B—lymph node—cervical cancer	0.00361	0.00834	CbGeAlD
Dipyridamole—Cramp muscle—Topotecan—cervical cancer	0.00353	0.0251	CcSEcCtD
Dipyridamole—ABCC5—decidua—cervical cancer	0.0035	0.0081	CbGeAlD
Dipyridamole—SLC29A1—uterine cervix—cervical cancer	0.00338	0.0078	CbGeAlD
Dipyridamole—ADA—vagina—cervical cancer	0.00329	0.0076	CbGeAlD
Dipyridamole—PDE4A—female gonad—cervical cancer	0.00322	0.00745	CbGeAlD
Dipyridamole—SLC29A1—decidua—cervical cancer	0.00322	0.00743	CbGeAlD
Dipyridamole—SLC29A1—renal system—cervical cancer	0.00316	0.0073	CbGeAlD
Dipyridamole—SLC29A1—endometrium—cervical cancer	0.00305	0.00706	CbGeAlD
Dipyridamole—PDE5A—female reproductive system—cervical cancer	0.00301	0.00696	CbGeAlD
Dipyridamole—PDE10A—lymph node—cervical cancer	0.00301	0.00696	CbGeAlD
Dipyridamole—PDE2A—lymph node—cervical cancer	0.00301	0.00696	CbGeAlD
Dipyridamole—PDE1B—lymph node—cervical cancer	0.00298	0.0069	CbGeAlD
Dipyridamole—SLC29A1—mammalian vulva—cervical cancer	0.00295	0.00683	CbGeAlD
Dipyridamole—PDE3A—female reproductive system—cervical cancer	0.00293	0.00677	CbGeAlD
Dipyridamole—PDE8B—lymph node—cervical cancer	0.00287	0.00664	CbGeAlD
Dipyridamole—SLC29A1—uterus—cervical cancer	0.00281	0.0065	CbGeAlD
Dipyridamole—PDE3B—lymph node—cervical cancer	0.00281	0.00648	CbGeAlD
Dipyridamole—PDE5A—female gonad—cervical cancer	0.00274	0.00633	CbGeAlD
Dipyridamole—Haemoglobin—Topotecan—cervical cancer	0.00273	0.0194	CcSEcCtD
Dipyridamole—PDE5A—vagina—cervical cancer	0.00272	0.0063	CbGeAlD
Dipyridamole—Rhinitis—Topotecan—cervical cancer	0.00272	0.0193	CcSEcCtD
Dipyridamole—Haemorrhage—Topotecan—cervical cancer	0.00271	0.0193	CcSEcCtD
Dipyridamole—Hypoaesthesia—Topotecan—cervical cancer	0.0027	0.0192	CcSEcCtD
Dipyridamole—Pharyngitis—Topotecan—cervical cancer	0.00269	0.0191	CcSEcCtD
Dipyridamole—PDE3A—female gonad—cervical cancer	0.00267	0.00616	CbGeAlD
Dipyridamole—PDE8A—lymph node—cervical cancer	0.00258	0.00597	CbGeAlD
Dipyridamole—SLC29A1—female reproductive system—cervical cancer	0.00253	0.00585	CbGeAlD
Dipyridamole—ABCC5—female gonad—cervical cancer	0.00251	0.00579	CbGeAlD
Dipyridamole—PDE1A—lymph node—cervical cancer	0.0025	0.00578	CbGeAlD
Dipyridamole—ABCC5—vagina—cervical cancer	0.00249	0.00576	CbGeAlD
Dipyridamole—Angiopathy—Topotecan—cervical cancer	0.00246	0.0175	CcSEcCtD
Dipyridamole—Immune system disorder—Topotecan—cervical cancer	0.00245	0.0174	CcSEcCtD
Dipyridamole—Mediastinal disorder—Topotecan—cervical cancer	0.00244	0.0174	CcSEcCtD
Dipyridamole—Chills—Topotecan—cervical cancer	0.00243	0.0173	CcSEcCtD
Dipyridamole—Alopecia—Topotecan—cervical cancer	0.0024	0.017	CcSEcCtD
Dipyridamole—ABCC4—renal system—cervical cancer	0.00238	0.00551	CbGeAlD
Dipyridamole—SLC29A1—female gonad—cervical cancer	0.0023	0.00532	CbGeAlD
Dipyridamole—SLC29A1—vagina—cervical cancer	0.00229	0.00529	CbGeAlD
Dipyridamole—Back pain—Topotecan—cervical cancer	0.00228	0.0162	CcSEcCtD
Dipyridamole—Muscle spasms—Topotecan—cervical cancer	0.00227	0.0161	CcSEcCtD
Dipyridamole—Ill-defined disorder—Topotecan—cervical cancer	0.00219	0.0156	CcSEcCtD
Dipyridamole—Anaemia—Topotecan—cervical cancer	0.00218	0.0155	CcSEcCtD
Dipyridamole—Angioedema—Topotecan—cervical cancer	0.00216	0.0153	CcSEcCtD
Dipyridamole—Malaise—Topotecan—cervical cancer	0.00213	0.0151	CcSEcCtD
Dipyridamole—ADA—lymph node—cervical cancer	0.00213	0.00491	CbGeAlD
Dipyridamole—ABCC4—uterus—cervical cancer	0.00212	0.00491	CbGeAlD
Dipyridamole—PDE4A—lymph node—cervical cancer	0.00207	0.00479	CbGeAlD
Dipyridamole—Cough—Topotecan—cervical cancer	0.00206	0.0146	CcSEcCtD
Dipyridamole—Arthralgia—Topotecan—cervical cancer	0.00201	0.0143	CcSEcCtD
Dipyridamole—Myalgia—Topotecan—cervical cancer	0.00201	0.0143	CcSEcCtD
Dipyridamole—Chest pain—Topotecan—cervical cancer	0.00201	0.0143	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.002	0.0142	CcSEcCtD
Dipyridamole—Discomfort—Topotecan—cervical cancer	0.00199	0.0141	CcSEcCtD
Dipyridamole—Anaphylactic shock—Topotecan—cervical cancer	0.00193	0.0137	CcSEcCtD
Dipyridamole—ABCC4—female reproductive system—cervical cancer	0.00191	0.00441	CbGeAlD
Dipyridamole—Nervous system disorder—Topotecan—cervical cancer	0.00189	0.0134	CcSEcCtD
Dipyridamole—Thrombocytopenia—Topotecan—cervical cancer	0.00189	0.0134	CcSEcCtD
Dipyridamole—Skin disorder—Topotecan—cervical cancer	0.00187	0.0133	CcSEcCtD
Dipyridamole—Hyperhidrosis—Topotecan—cervical cancer	0.00186	0.0132	CcSEcCtD
Dipyridamole—PDE5A—lymph node—cervical cancer	0.00176	0.00407	CbGeAlD
Dipyridamole—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00176	0.0125	CcSEcCtD
Dipyridamole—ABCC4—female gonad—cervical cancer	0.00174	0.00402	CbGeAlD
Dipyridamole—Paraesthesia—Topotecan—cervical cancer	0.00173	0.0123	CcSEcCtD
Dipyridamole—Dyspnoea—Topotecan—cervical cancer	0.00172	0.0122	CcSEcCtD
Dipyridamole—PDE3A—lymph node—cervical cancer	0.00171	0.00396	CbGeAlD
Dipyridamole—Dyspepsia—Topotecan—cervical cancer	0.0017	0.0121	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Topotecan—cervical cancer	0.00166	0.0118	CcSEcCtD
Dipyridamole—Fatigue—Topotecan—cervical cancer	0.00166	0.0118	CcSEcCtD
Dipyridamole—Pain—Topotecan—cervical cancer	0.00165	0.0117	CcSEcCtD
Dipyridamole—ABCC5—lymph node—cervical cancer	0.00161	0.00372	CbGeAlD
Dipyridamole—Feeling abnormal—Topotecan—cervical cancer	0.00159	0.0113	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Topotecan—cervical cancer	0.00158	0.0112	CcSEcCtD
Dipyridamole—Urticaria—Topotecan—cervical cancer	0.00153	0.0109	CcSEcCtD
Dipyridamole—Abdominal pain—Topotecan—cervical cancer	0.00152	0.0108	CcSEcCtD
Dipyridamole—SLC29A1—lymph node—cervical cancer	0.00148	0.00342	CbGeAlD
Dipyridamole—Hypersensitivity—Topotecan—cervical cancer	0.00142	0.0101	CcSEcCtD
Dipyridamole—Asthenia—Topotecan—cervical cancer	0.00138	0.00982	CcSEcCtD
Dipyridamole—Pruritus—Topotecan—cervical cancer	0.00136	0.00969	CcSEcCtD
Dipyridamole—Diarrhoea—Topotecan—cervical cancer	0.00132	0.00937	CcSEcCtD
Dipyridamole—Dizziness—Topotecan—cervical cancer	0.00127	0.00905	CcSEcCtD
Dipyridamole—Vomiting—Topotecan—cervical cancer	0.00123	0.0087	CcSEcCtD
Dipyridamole—Rash—Topotecan—cervical cancer	0.00122	0.00863	CcSEcCtD
Dipyridamole—Dermatitis—Topotecan—cervical cancer	0.00121	0.00862	CcSEcCtD
Dipyridamole—Headache—Topotecan—cervical cancer	0.00121	0.00858	CcSEcCtD
Dipyridamole—Nausea—Topotecan—cervical cancer	0.00114	0.00813	CcSEcCtD
Dipyridamole—ABCC4—lymph node—cervical cancer	0.00112	0.00258	CbGeAlD
Dipyridamole—ABCB1—epithelium—cervical cancer	0.000895	0.00207	CbGeAlD
Dipyridamole—ABCB1—uterine cervix—cervical cancer	0.000887	0.00205	CbGeAlD
Dipyridamole—ABCB1—decidua—cervical cancer	0.000845	0.00195	CbGeAlD
Dipyridamole—ABCB1—renal system—cervical cancer	0.00083	0.00192	CbGeAlD
Dipyridamole—ABCB1—endometrium—cervical cancer	0.000802	0.00185	CbGeAlD
Dipyridamole—ABCB1—mammalian vulva—cervical cancer	0.000776	0.00179	CbGeAlD
Dipyridamole—ABCB1—uterus—cervical cancer	0.000739	0.00171	CbGeAlD
Dipyridamole—ABCB1—female reproductive system—cervical cancer	0.000665	0.00154	CbGeAlD
Dipyridamole—ABCB1—female gonad—cervical cancer	0.000605	0.0014	CbGeAlD
Dipyridamole—ABCB1—vagina—cervical cancer	0.000601	0.00139	CbGeAlD
Dipyridamole—ABCB1—lymph node—cervical cancer	0.000389	0.000899	CbGeAlD
Dipyridamole—PDE1B—Signaling Pathways—AKAP13—cervical cancer	0.000168	0.000394	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—CASP8—cervical cancer	0.000167	0.000391	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—HES1—cervical cancer	0.000165	0.000386	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—NOTCH1—cervical cancer	0.000164	0.000384	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—STAT3—cervical cancer	0.000164	0.000384	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—STAT3—cervical cancer	0.000164	0.000384	CbGpPWpGaD
Dipyridamole—PDE10A—Hemostasis—TP53—cervical cancer	0.000162	0.00038	CbGpPWpGaD
Dipyridamole—PDE5A—Hemostasis—TP53—cervical cancer	0.000162	0.00038	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TERT—cervical cancer	0.000162	0.000379	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TERT—cervical cancer	0.000162	0.000379	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—FGFR3—cervical cancer	0.00016	0.000375	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—WNT5A—cervical cancer	0.000159	0.000372	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by NGF—EGFR—cervical cancer	0.000154	0.000362	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—CASP8—cervical cancer	0.000152	0.000357	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TERT—cervical cancer	0.00015	0.000352	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—NOTCH1—cervical cancer	0.00015	0.000352	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—EGFR—cervical cancer	0.00015	0.000352	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—EGFR—cervical cancer	0.00015	0.000352	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—MTOR—cervical cancer	0.00015	0.000351	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—CD4—cervical cancer	0.00015	0.000351	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—EGFR—cervical cancer	0.000149	0.000349	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—EGFR—cervical cancer	0.000149	0.000349	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HLA-DQB1—cervical cancer	0.000149	0.000348	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—FGFR3—cervical cancer	0.000149	0.000348	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—FGFR3—cervical cancer	0.000149	0.000348	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—MTOR—cervical cancer	0.000148	0.000348	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—MTOR—cervical cancer	0.000148	0.000348	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TERT—cervical cancer	0.000148	0.000347	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—EGFR—cervical cancer	0.000146	0.000343	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—WNT5A—cervical cancer	0.000145	0.00034	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TERT—cervical cancer	0.000144	0.000338	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—NOTCH1—cervical cancer	0.000139	0.000327	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—NOTCH1—cervical cancer	0.000139	0.000327	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD8A—cervical cancer	0.000139	0.000325	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—MTOR—cervical cancer	0.000138	0.000324	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—CD4—cervical cancer	0.000138	0.000324	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—FGFR3—cervical cancer	0.000138	0.000323	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—MTOR—cervical cancer	0.000137	0.000321	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—CD4—cervical cancer	0.000137	0.000321	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—MTOR—cervical cancer	0.000136	0.00032	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—CASP3—cervical cancer	0.000136	0.00032	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—CASP3—cervical cancer	0.000136	0.00032	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—CD4—cervical cancer	0.000136	0.000319	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-DQB1—cervical cancer	0.000136	0.000319	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—FGFR3—cervical cancer	0.000136	0.000318	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—EGFR—cervical cancer	0.000134	0.000313	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—CTNNB1—cervical cancer	0.000133	0.000311	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—FGFR3—cervical cancer	0.000132	0.00031	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—MTHFR—cervical cancer	0.000132	0.000309	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—CTNNB1—cervical cancer	0.000131	0.000308	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—CTNNB1—cervical cancer	0.000131	0.000308	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—HES1—cervical cancer	0.00013	0.000305	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—HES1—cervical cancer	0.00013	0.000305	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NOTCH2—cervical cancer	0.00013	0.000305	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—NOTCH1—cervical cancer	0.000129	0.000303	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—NOTCH1—cervical cancer	0.000128	0.000299	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD8A—cervical cancer	0.000127	0.000297	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—MTOR—cervical cancer	0.000126	0.000296	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—MTOR—cervical cancer	0.000126	0.000296	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—MTOR—cervical cancer	0.000125	0.000294	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—CD4—cervical cancer	0.000125	0.000293	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—NOTCH1—cervical cancer	0.000124	0.000291	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—EGFR—cervical cancer	0.000124	0.000291	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—EGFR—cervical cancer	0.000124	0.000291	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—MTOR—cervical cancer	0.000123	0.000288	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—CTNNB1—cervical cancer	0.000123	0.000288	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NOTCH2—cervical cancer	0.000122	0.000285	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—CTNNB1—cervical cancer	0.000122	0.000285	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—CTNNB1—cervical cancer	0.000121	0.000284	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HES1—cervical cancer	0.000119	0.000279	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NOTCH2—cervical cancer	0.000118	0.000277	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—CASP3—cervical cancer	0.000116	0.000272	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—CASP3—cervical cancer	0.000116	0.000272	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—STAT3—cervical cancer	0.000116	0.000271	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—EGFR—cervical cancer	0.000115	0.00027	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—STAT3—cervical cancer	0.000115	0.000269	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—STAT3—cervical cancer	0.000115	0.000269	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MTHFR—cervical cancer	0.000114	0.000268	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MTHFR—cervical cancer	0.000114	0.000268	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TERT—cervical cancer	0.000114	0.000268	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TERT—cervical cancer	0.000114	0.000268	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—FGFR3—cervical cancer	0.000113	0.000266	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—CASP3—cervical cancer	0.000113	0.000265	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MTOR—cervical cancer	0.000112	0.000263	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—CTNNB1—cervical cancer	0.000112	0.000262	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—CTNNB1—cervical cancer	0.000112	0.000262	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NOTCH2—cervical cancer	0.000111	0.000261	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—CTNNB1—cervical cancer	0.000111	0.000261	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000111	0.00026	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—EGFR—cervical cancer	0.000111	0.00026	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—CTNNB1—cervical cancer	0.000109	0.000255	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—STAT3—cervical cancer	0.000107	0.000251	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—HES1—cervical cancer	0.000107	0.00025	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—STAT3—cervical cancer	0.000105	0.000247	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—EGFR—cervical cancer	0.000105	0.000247	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—TP53—cervical cancer	0.000105	0.000246	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—FGFR3—cervical cancer	0.000105	0.000246	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—FGFR3—cervical cancer	0.000105	0.000246	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MTHFR—cervical cancer	0.000105	0.000245	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MTOR—cervical cancer	0.000104	0.000245	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MTOR—cervical cancer	0.000104	0.000245	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TERT—cervical cancer	0.000104	0.000245	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—EGFR—cervical cancer	0.000104	0.000244	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—EGFR—cervical cancer	0.000104	0.000244	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—FGFR3—cervical cancer	0.000104	0.000243	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CASP3—cervical cancer	0.000103	0.000242	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NOTCH2—cervical cancer	0.000102	0.000239	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—HES1—cervical cancer	9.98e-05	0.000234	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CTNNB1—cervical cancer	9.97e-05	0.000234	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NOTCH1—cervical cancer	9.84e-05	0.000231	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NOTCH1—cervical cancer	9.84e-05	0.000231	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—STAT3—cervical cancer	9.75e-05	0.000228	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—STAT3—cervical cancer	9.75e-05	0.000228	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—EGFR—cervical cancer	9.72e-05	0.000228	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—HES1—cervical cancer	9.7e-05	0.000227	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CASP8—cervical cancer	9.7e-05	0.000227	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MTOR—cervical cancer	9.69e-05	0.000227	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—EGFR—cervical cancer	9.63e-05	0.000226	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CASP3—cervical cancer	9.61e-05	0.000225	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CASP3—cervical cancer	9.61e-05	0.000225	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—MTHFR—cervical cancer	9.59e-05	0.000225	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—EGFR—cervical cancer	9.59e-05	0.000225	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—FGFR3—cervical cancer	9.58e-05	0.000225	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MTOR—cervical cancer	9.56e-05	0.000224	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—TP53—cervical cancer	9.55e-05	0.000224	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—STAT3—cervical cancer	9.5e-05	0.000223	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TERT—cervical cancer	9.34e-05	0.000219	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MTOR—cervical cancer	9.31e-05	0.000218	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CTNNB1—cervical cancer	9.26e-05	0.000217	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CTNNB1—cervical cancer	9.26e-05	0.000217	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—HES1—cervical cancer	9.12e-05	0.000214	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NOTCH1—cervical cancer	9e-05	0.000211	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—TP53—cervical cancer	8.98e-05	0.00021	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CASP3—cervical cancer	8.91e-05	0.000209	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CASP8—cervical cancer	8.87e-05	0.000208	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—EGFR—cervical cancer	8.86e-05	0.000208	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—EGFR—cervical cancer	8.86e-05	0.000208	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—EGFR—cervical cancer	8.8e-05	0.000206	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CASP3—cervical cancer	8.79e-05	0.000206	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TP53—cervical cancer	8.75e-05	0.000205	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TP53—cervical cancer	8.75e-05	0.000205	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TERT—cervical cancer	8.74e-05	0.000205	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—STAT3—cervical cancer	8.69e-05	0.000204	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—EGFR—cervical cancer	8.63e-05	0.000202	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CTNNB1—cervical cancer	8.59e-05	0.000201	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—FGFR3—cervical cancer	8.57e-05	0.000201	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CASP3—cervical cancer	8.57e-05	0.000201	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TERT—cervical cancer	8.5e-05	0.000199	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CTNNB1—cervical cancer	8.47e-05	0.000199	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	8.39e-05	0.000197	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HES1—cervical cancer	8.34e-05	0.000196	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CTNNB1—cervical cancer	8.26e-05	0.000194	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TP53—cervical cancer	8.21e-05	0.000192	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	8.09e-05	0.00019	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—STAT3—cervical cancer	8.08e-05	0.000189	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—STAT3—cervical cancer	8.08e-05	0.000189	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NOTCH1—cervical cancer	8.04e-05	0.000189	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—FGFR3—cervical cancer	8.02e-05	0.000188	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TERT—cervical cancer	7.99e-05	0.000187	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—MTOR—cervical cancer	7.98e-05	0.000187	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD4—cervical cancer	7.97e-05	0.000187	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—EGFR—cervical cancer	7.9e-05	0.000185	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—FGFR3—cervical cancer	7.8e-05	0.000183	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NOTCH1—cervical cancer	7.53e-05	0.000177	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—STAT3—cervical cancer	7.49e-05	0.000176	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—cervical cancer	7.44e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—cervical cancer	7.44e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—STAT3—cervical cancer	7.39e-05	0.000173	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MTOR—cervical cancer	7.37e-05	0.000173	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MTOR—cervical cancer	7.37e-05	0.000173	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CD4—cervical cancer	7.36e-05	0.000172	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CD4—cervical cancer	7.36e-05	0.000172	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—EGFR—cervical cancer	7.34e-05	0.000172	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—EGFR—cervical cancer	7.34e-05	0.000172	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—FGFR3—cervical cancer	7.34e-05	0.000172	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NOTCH1—cervical cancer	7.33e-05	0.000172	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TERT—cervical cancer	7.31e-05	0.000171	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—MTOR—cervical cancer	7.3e-05	0.000171	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD4—cervical cancer	7.29e-05	0.000171	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—cervical cancer	7.25e-05	0.00017	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—STAT3—cervical cancer	7.2e-05	0.000169	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—EGFR—cervical cancer	7.17e-05	0.000168	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CTNNB1—cervical cancer	7.08e-05	0.000166	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NOTCH1—cervical cancer	6.89e-05	0.000161	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—EGFR—cervical cancer	6.8e-05	0.00016	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MTOR—cervical cancer	6.74e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CD4—cervical cancer	6.73e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—EGFR—cervical cancer	6.71e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FGFR3—cervical cancer	6.71e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—EGFR—cervical cancer	6.71e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—cervical cancer	6.63e-05	0.000155	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—EGFR—cervical cancer	6.54e-05	0.000153	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CTNNB1—cervical cancer	6.53e-05	0.000153	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CTNNB1—cervical cancer	6.53e-05	0.000153	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—EGFR—cervical cancer	6.53e-05	0.000153	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CA9—cervical cancer	6.49e-05	0.000152	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CTNNB1—cervical cancer	6.47e-05	0.000152	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	6.41e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NOTCH1—cervical cancer	6.3e-05	0.000148	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—cervical cancer	6.22e-05	0.000146	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—STAT3—cervical cancer	6.17e-05	0.000145	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—cervical cancer	6.16e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—cervical cancer	6.16e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—EGFR—cervical cancer	6.14e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MTOR—cervical cancer	6.03e-05	0.000141	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CTNNB1—cervical cancer	5.98e-05	0.00014	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—cervical cancer	5.71e-05	0.000134	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—STAT3—cervical cancer	5.7e-05	0.000134	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—STAT3—cervical cancer	5.7e-05	0.000134	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MTOR—cervical cancer	5.64e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—STAT3—cervical cancer	5.64e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—cervical cancer	5.64e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—EGFR—cervical cancer	5.61e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EGFR—cervical cancer	5.61e-05	0.000131	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CASP3—cervical cancer	5.54e-05	0.00013	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—cervical cancer	5.49e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MTOR—cervical cancer	5.49e-05	0.000129	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	5.38e-05	0.000126	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CTNNB1—cervical cancer	5.34e-05	0.000125	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—STAT3—cervical cancer	5.21e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CASP3—cervical cancer	5.19e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EGFR—cervical cancer	5.18e-05	0.000121	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EGFR—cervical cancer	5.18e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MTOR—cervical cancer	5.16e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EGFR—cervical cancer	5.13e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CASP3—cervical cancer	5.05e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CTNNB1—cervical cancer	5e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CTNNB1—cervical cancer	4.87e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CASP3—cervical cancer	4.75e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EGFR—cervical cancer	4.73e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MTOR—cervical cancer	4.72e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—STAT3—cervical cancer	4.66e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CTNNB1—cervical cancer	4.58e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—STAT3—cervical cancer	4.36e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CASP3—cervical cancer	4.34e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—STAT3—cervical cancer	4.24e-05	9.94e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EGFR—cervical cancer	4.23e-05	9.92e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CTNNB1—cervical cancer	4.18e-05	9.81e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—STAT3—cervical cancer	3.99e-05	9.35e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EGFR—cervical cancer	3.96e-05	9.29e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EGFR—cervical cancer	3.86e-05	9.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—STAT3—cervical cancer	3.65e-05	8.55e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGFR—cervical cancer	3.63e-05	8.5e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—cervical cancer	3.55e-05	8.33e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—cervical cancer	3.33e-05	7.8e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGFR—cervical cancer	3.32e-05	7.77e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—cervical cancer	3.24e-05	7.59e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—cervical cancer	3.04e-05	7.13e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—cervical cancer	2.78e-05	6.53e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MTHFR—cervical cancer	2.63e-05	6.18e-05	CbGpPWpGaD
